CUSIP: 45780V102
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,874,608
-
Share change
-
-2,067,582
-
Total reported value
-
$14,955,008
-
Put/Call ratio
-
8.5%
-
Price per share
-
$1.90
-
Number of holders
-
47
-
Value change
-
-$4,014,656
-
Number of buys
-
16
-
Number of sells
-
41
Quarterly Holders Quick Answers
What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2017
-
Previous quarter:
Q1 2017
Recent filing periods for CUSIP 45780V102:
Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q2 2017
As of 30 Jun 2017,
INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,874,608 shares.
The largest 10 holders included
RHO CAPITAL PARTNERS INC, SENZAR ASSET MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., SPHERA FUNDS MANAGEMENT LTD., COLUMBUS CIRCLE INVESTORS, BlackRock Inc., VANGUARD GROUP INC, DAFNA Capital Management LLC, MILLENNIUM MANAGEMENT LLC, and SABBY MANAGEMENT, LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.